HR20013 for Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
Clinical trial NCT06554184 · COMPLETED
Trial details
- NCT number
- NCT06554184
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-03
- Primary completion
- 2025-07-28
- Enrollment
- 706
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.